Long-term oncologic outcome of D3 lymph node dissection for clinical stage 2/3 right-sided colon cancer
暂无分享,去创建一个
S. Baek | Sun-il Lee | W. Ji | B. Min | J. Kwak | J. Um | K. Hong | Y. Ju | Sunseok Yoon | Jin Kim | Sanghee L. Kang | Jung Sik Kim
[1] A. Giani,et al. Mid-term oncological outcomes after complete versus conventional mesocolic excision for right-sided colon cancer: a propensity score matching analysis , 2022, Surgical Endoscopy.
[2] M. Fernández-Hevia,et al. Complete Mesocolic Excision and D3 Lymphadenectomy versus Conventional Colectomy for Colon Cancer: A Systematic Review and Meta-Analysis , 2021, Annals of Surgical Oncology.
[3] I. Shaikh,et al. Complete mesocolic excision versus conventional surgery for colon cancer: A systematic review and meta‐analysis , 2021, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[4] S. Baek,et al. Impact of D3 lymph node dissection on upstaging and short-term survival in clinical stage I right-sided colon cancer. , 2021, Asian journal of surgery.
[5] A. Heriot,et al. Oncological reasons for performing a complete mesocolic excision: a systematic review and meta‐analysis , 2021, ANZ journal of surgery.
[6] A. Toniato,et al. Complete mesocolic excision versus conventional hemicolectomy in patients with right colon cancer: a systematic review and meta-analysis , 2020, International Journal of Colorectal Disease.
[7] S. Achkasov,et al. Short‐term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial) , 2019, The British journal of surgery.
[8] J. Monson,et al. Examining the relationship between lymph node harvest and survival in patients undergoing colectomy for colon adenocarcinoma. , 2019, Surgery.
[9] Masahiro Yoshida,et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer , 2019, International Journal of Clinical Oncology.
[10] J. Oh,et al. Characteristics and Survival of Korean Patients With Colorectal Cancer Based on Data From the Korea Central Cancer Registry Data , 2018, Annals of coloproctology.
[11] Huadan Xue,et al. The Radical Extent of lymphadenectomy — D2 dissection versus complete mesocolic excision of LAparoscopic Right Colectomy for right-sided colon cancer (RELARC) trial: study protocol for a randomized controlled trial , 2016, Trials.
[12] K. Matzel,et al. Prognosis of patients with colonic carcinoma before, during and after implementation of complete mesocolic excision , 2016, The British journal of surgery.
[13] F. Pfeffer,et al. Bowel function and quality of life after superior mesenteric nerve plexus transection in right colectomy with D3 extended mesenterectomy , 2016, Techniques in Coloproctology.
[14] J. E. Jansen,et al. Short‐term outcomes after complete mesocolic excision compared with ‘conventional’ colonic cancer surgery , 2016, The British journal of surgery.
[15] Y. Kim,et al. Short-term and oncologic outcomes of laparoscopic and open complete mesocolic excision and central ligation. , 2016, International journal of surgery.
[16] J. Sandbank,et al. Influence of colectomy type and resected specimen length on number of harvested lymph nodes. , 2015, International journal of surgery.
[17] J. E. Jansen,et al. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study. , 2015, The Lancet. Oncology.
[18] D. Winter,et al. Complete mesocolic resection and extended lymphadenectomy for colon cancer: a systematic review , 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[19] K. Sugihara,et al. Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer , 2014, International Journal of Colorectal Disease.
[20] G. Eide,et al. Short term results of complete (D3) vs. standard (D2) mesenteric excision in colon cancer shows improved outcome of complete mesenteric excision in patients with TNM stages I-II , 2014, Techniques in Coloproctology.
[21] W. Hohenberger,et al. The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery , 2014, International Journal of Colorectal Disease.
[22] B. Edwin,et al. Lymph Node Distribution in the D3 Area of the Right Mesocolon: Implications for an Anatomically Correct Cancer Resection. A Postmortem Study , 2013, Diseases of the colon and rectum.
[23] D. Sargent,et al. Surgical Quality Surrogates Do Not Predict Colon Cancer Survival in the Setting of Technical Credentialing: A Report from the Prospective COST Trial , 2013, Annals of surgery.
[24] M. Zheng,et al. Long-term results of laparoscopy-assisted radical right hemicolectomy with D3 lymphadenectomy: clinical analysis with 177 cases , 2013, International Journal of Colorectal Disease.
[25] C. Compton,et al. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.
[26] T. Hickish,et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] K. Matzel,et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation – technical notes and outcome , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[28] V. Tsikitis,et al. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved. , 2009, Journal of the American College of Surgeons.
[29] P. Catalano,et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] F. Mosca,et al. Prognostic Evaluation of Stage B Colon Cancer Patients is Improved by an Adequate Lymphadenectomy: Results of a Secondary Analysis of a Large Scale Adjuvant Trial , 2002, Annals of surgery.